<PAGE> 1
COMPANY DATA:
COMPANY CONFORMED NAME: MEDICIS PHARMACEUTICAL CORPORATION
CENTRAL INDEX KEY: [ ]
STANDARD INDUSTRIAL CLASSIFICATION 2834
IRS NUMBER: 52-1574808
STATE OF INCORPORATION: DELAWARE
FISCAL YEAR END: 0630
FILING VALUES:
FORM TYPE: 11-K
SEC ACT: 1933 Act
SEC FILE NUMBER: 333-
FILM NUMBER:
BUSINESS ADDRESS:
STREET 1: 4343 EAST CAMELBACK ROAD
STREET 2: SUITE 250
CITY: PHOENIX
STATE: ARIZONA
ZIP: 85018
BUSINESS PHONE: 602-808-8800
MAIL ADDRESS:
STREET 1: 4343 EAST CAMELBACK ROAD
STREET 2: SUITE 250
CITY: PHOENIX
STATE: ARIZONA
ZIP: 85018
As filed with the Securities and Exchange Commission on November 21, 1997
Registration No. 333- ________________________
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 11-K
FOR ANNUAL REPORTS OF EMPLOYEE STOCK PURCHASE, SAVINGS AND SIMILAR
PLANS PURSUANT TO SECTION 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
(X) ANNUAL REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the plan year ended December 31, 1996
or
( ) TRANSITION REPORT PURSUANT TO SECTION 15(d) OF THE SECURITIES
EXCHANGE ACT OF 1934
For the transition period from __________ to __________
Commission File Number:
Full title of the plan and the address of the plan, if different from
that of the issuer named below:
Medicis Pharmaceutical Corporation 401(k) Plan
Name of issuer of the securities held pursuant to the plan and the address of
its principal executive office:
Medicis Pharmaceutical Corporation
4343 East Camelback Road, Suite 250
Phoenix, Arizona 85018
<PAGE> 2
MEDICIS PHARMACEUTICAL CORPORATION 401(K) PLAN
FINANCIAL STATEMENTS
STATEMENT OF ASSETS AND LIABILITIES
FOR THE PLAN YEAR ENDED DECEMBER 31, 1996
<TABLE>
<CAPTION>
ASSETS BEGINNING OF YEAR END OF YEAR
<S> <C> <C>
Cash ....................................... $ 58,328 $ 45,224
Investments:
Corporate Debt and Equity Instruments . 323,115 557,722
Loans to Participants 17,400 25,849
-------- --------
TOTAL ASSETS .......................... $398,843 $628,795
======== ========
LIABILITIES
Payables ................................... 0 0
Acquisition indebtedness ................... 0 0
Other liabilities .......................... 0 0
-------- --------
TOTAL LIABILITIES .............. $ 0 $ 0
======== ========
NET ASSETS ..................... $398,843 $628,795
</TABLE>
INCOME STATEMENT
FOR THE PLAN YEARS ENDED DECEMBER 31, 1996
<TABLE>
<CAPTION>
INCOME AMOUNT TOTAL
<S> <C> <C>
Contributions received or receivable in cash from:
Employees ............................................... $191,388
Participants Rollovers/Transfers ........................ 26,481
Earnings from investments (interest, dividends, rents, royalties) .. 2,518
Other Income - unrealized appreciation ............................. 67,868
--------
TOTAL INCOME $288,255
========
EXPENSES
Distribution of benefits and payments to provide benefits directly to $ 58,303
participants or their beneficiaries .................................
TOTAL EXPENSES ......................................... $ 58,303
========
NET INCOME ............................................. $229,952
</TABLE>
<PAGE> 3
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934,
Medicis Pharmaceutical Corporation, as Plan Administrator with respect to the
Medicis Pharmaceutical Corporation 401(k) Plan, has duly caused this annual
report to be signed on its behalf by the undersigned hereunto duly authorized.
MEDICIS PHARMACEUTICAL CORPORATION
401(k) PLAN
Date: November 21, 1997. By: /s/ Mark A. Prygocki,Sr.
-------------------------
Mark A. Prygocki, Sr.,
Chief Financial Officer
